Proven efficacy for moderate to
severe acute pain
POWERFUL
EFFICACY
See phase 3 data demonstrating the strength of NUCYNTA for patients with moderate to severe acute pain.
CO‑PAY SAVINGS
AVAILABLE FOR ELIGIBLE PATIENTS
Learn about our co‑pay savings offer for your commercially insured patients.